Get started
Author

Lurdes Planas‐Cerezales

Observed names: L Planas-Cerezales, L. Planas-Cerezales, Lurdes Planas, Lurdes Planas Cerezales, Lurdes Planas-Cerezales, Planas Cerezales, Lurdes, Planas-Cerezales, Lurdes
Observed institutions: Instituto de Salud Carlos III, Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Hospital de Viladecans, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Sociedad Española de Neumología y Cirugía Torácica, Universitat de Barcelona
ORCID: 0000-0001-7636-444X
Observed ORCID: 0000-0001-7636-444X
OpenAlex ID: A5072838339
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants
2023 · Anna L. Peljto, Rachel Z. Blumhagen, et al. · American Journal of Respiratory and Critical Care Medicine · 89
PDF
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey
2019 · Catharina C. Moor, Marlies S. Wijsenbeek, et al. · ERJ Open Research · 64
PDF
Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis
2018 · Lurdes Planas‐Cerezales, Elena G. Arias‐Salgado, et al. · Respirology · 56
Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
2018 · Carlos Machahua, Ana Montes-Worboys, et al. · Respiratory Research · 48
PDF
Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes
2019 · Elena G. Arias-Salgado, Eva Galvez, et al. · Orphanet Journal of Rare Diseases · 35
PDF
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers
2020 · Jessica Germaine Shull, Maria Teresa Pay, et al. · Respirology · 30
Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
2021 · Carlos Machahua, Sabina A. Guler, et al. · BMJ Open Respiratory Research · 28
PDF
Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction
2021 · Lurdes Planas-Cerezales, Elena G. Arias-Salgado, et al. · Frontiers in Medicine · 26
PDF
Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis
2018 · Mariel Maldonado, Ivette Buendía-Roldán, et al. · PLoS ONE · 24
PDF
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
2021 · Guadalupe Bermudo, Guillermo Suarez-Cuartin, et al. · Archivos de Bronconeumología · 13
GSE4‐loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage
2021 · Laura Pintado‐Berninches, Ana Montes‐Worboys, et al. · The FASEB Journal · 12
PDF
Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome
2021 · Jaume Bordas-Martínez, Ricard Gavaldà, et al. · ERJ Open Research · 11
PDF
Acortamiento de los telómeros en fibrosis pulmonar idiopática
2017 · María Molina-Molina, Lurdes Planas-Cerezales, et al. · Archivos de Bronconeumología · 9
Telomere Shortening in Idiopathic Pulmonary Fibrosis
2017 · María Molina-Molina, Lurdes Planas-Cerezales, et al. · Archivos de Bronconeumología · 6
Diagnostic and prognostic implications of family history of fibrotic interstitial lung diseases
2024 · D. Duminy-Luppi, A. Alcaide-Aldeano, et al. · Respiratory Research · 4
PDF
Add-on therapy for pulmonary fibrosis, a forthcoming era with implications for practice: the BI 101550 and RELIEF trials
2023 · Lurdes Planas-Cerezales, Laura Fabbri, et al. · Breathe · 4
PDF
Harnessing PM2.5 Exposure Data to Predict Progression of Fibrotic Interstitial Lung Diseases Based on Telomere Length
2022 · Jessica Germaine Shull, Lurdes Planas-Cerezales, et al. · Frontiers in Medicine · 4
Familial interstitial lung disease: emerging insights into screening and genetic risk
2026 · Ana Paola Hernández Cristancho, Lurdes Planas-Cerezales, et al. · Frontiers in Medicine · 3
PDF
Mapping IPF helps identify geographic regions at higher risk for disease development
2020 · Jessica Shull, Oriol Jorba, et al. · European Respiratory Journal · 3
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror Those of European Populations
2025 · Anna L Peljto, Haruhiko Furusawa, et al. · American Journal of Respiratory and Critical Care Medicine · 2
ERS Congress 2024: highlights from the Interstitial Lung Diseases Assembly
2025 · Laura Fabbri, Malik A. Althobiani, et al. · ERJ Open Research · 2
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
2016 · Pilar Rivera Ortega, Patricio Luburich, et al. · European Respiratory Journal · 2
Preserved Forced Vital Capacity is not Always Representing Early IPF
2020 · Guadalupe Bermudo Peloche, Guillermo Suárez-Cuartin, et al. · European Respiratory Journal · 1
Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases
2019 · Ana Belén Llanos-González, Jaume Bordas Martínez, et al. · European Respiratory Journal · 1
Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening
2017 · Marta Garcia Moyano, Lurdes Planas, et al. · European Respiratory Journal · 1
Works count: 53
Citation count: 480
H-index: 11
I10-index: 12
Year
Topic
Type